Navigation Links
Exagen's Corporate Expansion Creates Job Opportunities in New Mexico
Date:1/25/2011

ALBUQUERQUE, N.M., Jan. 25, 2011 /PRNewswire/ -- Exagen Diagnostics, Inc., a specialty diagnostics laboratory that discovers, develops and markets proprietary tests, announced today the completion of the company's office expansion at the University of New Mexico Science and Technology Park. The expansion, which includes new space for both offices and a laboratory, allows Exagen to accommodate growing test volume for its gastroenterology products and the transition of the company's newly acquired rheumatology diagnostic products to Albuquerque.

"We are pleased to see the rapid adoption of our gene expression tests for the diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome," said Scott Glenn, Exagen CEO. "New Mexico is a wonderful environment to build a business, and our success will create an ongoing need for employees in operations, research and development, sales and marketing."

In the coming year, Exagen plans to double its sales force and hire 16 additional employees, including technical lab personnel, marketing directors, customer service and billing staff. Sales force personnel will be geographically based; all others will be based in Albuquerque.

In addition to commercial laboratory testing, Exagen has an active Research and Development group that will use some of the new space to complete various programs in both rheumatology and gastroenterology. With a commitment to personalized medicine, Exagen is focused on discovering and developing tests for individualized diagnostic information. A number of products are expected to be launched in 2011 and 2012.

About Exagen Diagnostics, Inc.

Exagen Diagnostics is the emerging leader in laboratory-discovered and developed diagnostic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna®, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified via traditional analytical methods. For more information, please visit www.exagen.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
6. AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Hypermarcas S.A. ("Hypermarcas") today announced that ... "Tender Offer") to purchase any and all of ... its 6.500% Senior Notes due 2021 (CUSIP Nos. ... "Notes"). In connection with the Tender Offer, Hypermarcas ... "Consents") of the holders of the Notes (the ...
(Date:2/12/2016)... 12, 2016 ... http://www.sedar.com ) und der ... abrufbar.    --> http://www.sedar.com ) ... http://www.telestatherapeutics.com abrufbar.    --> ... seinen Konzernabschluss des zweiten Quartals und ...
(Date:2/12/2016)... -- Memorial Hermann Health System has teamed up with Houston ... a one-of-a-kind experience to pediatric patients at Children,s ... 360-degree video and Google Cardboard, Howard was able to ... the patients and their families an unexpected, and energetically ... video . Memorial Hermann IRONMAN Sports ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... ... February 12, 2016 , ... For Coast Dental dentist ... Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer at ... dental professionals, donating their time and skills to help hundreds of uninsured and underinsured ...
(Date:2/12/2016)... New York, NY (PRWEB) , ... February 12, ... ... latest edition of “Revolutionizing Cancer Care.” , The print component of ... in Chicago, Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, Inc. ... and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health plans ... categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... US ... Des Moines, Iowa. Legacy Golf Club, located in Norwalk, serves as the host site ... the Year, Rob Randall. , “We have had successful camps in recent years around ...
Breaking Medicine News(10 mins):